Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $14.8800 (1.85%) ($14.8800 - $14.8800) on Mon. Apr. 25, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.99% (three month average) | RSI | 18 | Latest Price | $14.8800(1.85%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.1% a day on average for past five trading days. | Weekly Trend | EDIT declines -12.8% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(68%) IWO(62%) IWC(61%) IBUY(60%) IWM(59%) | Factors Impacting EDIT price | EDIT will decline at least -2.495% in a week (0% probabilities). VIXM(-29%) UUP(-15%) VXX(-10%) TBT(-9%) UNG(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.495% (StdDev 4.99%) | Hourly BBV | 0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-5.12(-134.41%) | Resistance Level | $17.78 | 5 Day Moving Average | $15(-0.8%) | 10 Day Moving Average | $16.08(-7.46%) | 20 Day Moving Average | $17.78(-16.31%) | To recent high | -30.2% | To recent low | 5.5% | Market Cap | $924m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |